Article

Ziemer Ophthalmics' femtosecond laser receives FDA clearance

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

Ziemer Ophthalmic Systems AG announces it has received clearance by the FDA to market the Da Vinci femtosecond surgical laser system.

The system's state-of-the-art laser technology generates shorter, smaller, lower-energy infrared laser pulses that dissect corneal tissue with unprecedented smoothness and precision, according to the company.

Shipment of the system, which designed for a wide range of applications in corneal surgery, is expected in June 2006.

For more information, visit Ziemer Ophthalmics at Booth 1010.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.